| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
180 Life Sciences Corp.
13D/A
ETHZ · 68236V302
|
1.5% |
8/6/2025
Event 7/24/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.